BioCentury
ARTICLE | Company News

Horizon Discovery Group plc, Zalicus Inc. deal

June 9, 2014 7:00 AM UTC

Horizon completed its acquisition of Zalicus' CombinatoRx combination high throughput screening (cHTS) business and related assets for $8 million. The business will become a subsidiary of Horizon and ...